a neanate
Conditions
Interventions
24%-sucrose group
12%-sucrose group
Sponsors
Tokyo Woman's Medical University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Infants who are less than 8 days after birth between 35 and 42 weeks of corrected age, and are hospitalized at the NICU in Tokyo Women's Medical University Hospital Infants who were enrolled after informed consent was obtained from their parents Infants whose legal guardians have fully understood after having received sufficient explanation about participation in this study and have given written consent at their free will Infants were enrolled if informed consent was obtained from at least 1 parent who had problems such as a single mother, perinatal death of a mother, and so on
Exclusion criteria
Exclusion criteria: Infants with congenital anomalies of intestines Infants with chromosomal anomalies Infants with multiple anomaly syndrome Infants with hyperglycemia who need insulin administration Infants whom the principal researcher has judged to be inappropriate as subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of the median of the Premature Infant Pain Profile (PIPP) score between 24 % oral sucrose and 12 % oral sucrose during heel lance: a double blind randomized trial | — |
Countries
Japan
Contacts
Public ContactChizuru Matsumoto
Tokyo Woman's Medical University Hospital kango-bu
Outcome results
None listed